Phase
Condition
Bronchitis (Pediatric)
Respiratory Syncytial Virus (Rsv) Infection
Treatment
N/AClinical Study ID
Ages 2-2 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Any infant with moderate bronchiolitis according to the HAS definition (except forthe SpO2 criterion which must be greater than or equal to 92% to avoid the patientbeing on oxygen therapy upon admission)
Age > 2 months and ≤ 2 years
Respiratory syndrome for 48 hours
Infant with a first episode of bronchiolitis
Referral of the general practitioner/treating pediatrician for home hospitalisationcare
Parents' agreement for the choice of home hospitalisation care
Non-opposition or free and informed consent of both parents to the use of thechild's health data
Exclusion
Exclusion Criteria:
Patient not receiving health protection
Comorbidities: congenital heart disease with shunt, chronic pulmonary pathologyincluding bronchopulmonary dysplasia, neuromuscular pathology, immune deficiency,multiple disabilities Congenital heart disease
Refusal of one or both parents for the proposed pathway
Doubts about the parents' understanding of the nature of home hospitalisation care
Severe bronchiolitis or with saturation < 92%
Moderate bronchiolitis but evolving for less than 48 hours
Cases of psychiatric pathologies or depressive syndrome diagnosed in theparents.
Study Design
Connect with a study center
Polyclinique de Poitiers - HAD
Poitiers, 86000
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.